Nomura Holdings
VERA icon

Nomura Holdings’s Vera Therapeutics VERA Stock Holding History

Nomura Holdings’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$862K Buy
+20,100
New +$749K ﹤0.01% 1400

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Nomura Holdings's VERA Position: Q2 2026 in Review

Nomura Holdings opened a new position in Vera Therapeutics (VERA) in Q2 2026: 5,000 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1675 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in VERA as recently as Q1 2024.

Nomura Holdings first reported a position in VERA in Q1 2024 and has held it in 2 quarters since. The position peaked at $600K in Q1 2024. 202 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Nomura Holdings held 5,000 shares of Vera Therapeutics worth $215K as of Q2 2026.
  • Vera Therapeutics was a new Nomura Holdings position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1675 holding.
  • Nomura Holdings first reported a position in Vera Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • Nomura Holdings's Vera Therapeutics position peaked at $600K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.